Literature DB >> 27714743

Circulation of Respiratory Syncytial Virus in Morocco during 2014-2016: Findings from a sentinel-based virological surveillance system for influenza.

A Bimouhen1, F El Falaki1, H Ihazmad1, Z Regragui1, S Benkerroum1, A Barakat1.   

Abstract

Respiratory syncytial virus (RSV) is a leading cause of mortality and morbidity in young infants, little was known on its circulation types and patterns in Morocco. We conducted a prospective study using sentinel-based influenza surveillance to detect RSV by real time PCR in patients with acute respiratory infections, enrolled during two seasons (2014/15, 2015/16). During September 2014-April 2016, we obtained 1450 specimens, of which 267(18.4%) tested positive for RSV. The proportion of positive RSV infection was higher in patients hospitalized with acute respiratory infection compared to those with mild symptoms in out-patient clinics. The proportion of RSV infection was highest in children aged 0-6 months (45%; P < 0.001). Higher positivity rate was observed between months of December and March. RSV remains important viral etiological agent causing influenza-like illness and severe acute respiratory infections especially among infants in Morocco. Further surveillance, is required to understand better the risk factors of RSV infections.

Entities:  

Mesh:

Year:  2016        PMID: 27714743

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  6 in total

1.  Influenza-associated severe acute respiratory infections among children under five years old in Morocco, September 2017 to March 2019.

Authors:  Zakia Regragui; Abderrahman Bimouhen; Fatima El Falaki; Hassan Ihazmad; Samira Benkerroum; Soumia Triki; Imad Cherkaoui; Chafiq Mahraoui; Abdelkarim Filali-Maltouf; Leila Medraoui; Hicham Oumzil
Journal:  Infez Med       Date:  2022-09-01

2.  Epidemiology and molecular characterization of influenza viruses in Burkina Faso, sub-Saharan Africa.

Authors:  Armel M Sanou; Sampoko Carine M Wandaogo; Armel Poda; Laure Tamini; Anselme E Kyere; Tani Sagna; Macaire S Ouedraogo; Maude Pauly; Judith M Hübschen; Claude P Muller; Zekiba Tarnagda; Chantal J Snoeck
Journal:  Influenza Other Respir Viruses       Date:  2018-04-24       Impact factor: 4.380

3.  Contemporaneous data on the prevalence of Human Respiratory Syncytial Virus infection in people with acute respiratory tract infections in Africa (2000-2017).

Authors:  Jean Joel Bigna; Sebastien Kenmoe; Estelle Amandine Well; Fredy Brice N Simo; Véronique B Penlap; Astrid Vabret; Richard Njouom
Journal:  Data Brief       Date:  2018-08-22

4.  Fourth meeting of the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network and first scientific conference on acute respiratory infections in the Eastern Mediterranean Region, 11-14 December, 2017, Amman, Jordan.

Authors:  Abdinasir Abubakar; Amal Barakat; Amira Ahmed; Amjad El Kholy; Lora Alsawalh; Lubna Al Ariqi; Mamunur Rahman Malik; Majdouline Obtel; Mohammad Sahak; Pamela Mrad; Soumia Triki; Salah Al Awaidy; Wasiq Mehmood Khan
Journal:  J Infect Public Health       Date:  2019-02-04       Impact factor: 3.718

5.  Prevalence of human respiratory syncytial virus infection in people with acute respiratory tract infections in Africa: A systematic review and meta-analysis.

Authors:  Sebastien Kenmoe; Jean Joel Bigna; Estelle Amandine Well; Fredy Brice N Simo; Véronique B Penlap; Astrid Vabret; Richard Njouom
Journal:  Influenza Other Respir Viruses       Date:  2018-07-05       Impact factor: 4.380

Review 6.  Fourth meeting of the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network and first scientific conference on acute respiratory infections in the Eastern Mediterranean Region, 11-14 December, 2017, Amman, Jordan.

Authors:  Abdinasir Abubakar; Amal Barakat; Amira Ahmed; Amjad El Kholy; Lora Alsawalh; Lubna Al Ariqi; Mamunur Rahman Malik; Majdouline Obtel; Mohammad Sahak; Pamela Mrad; Soumia Triki; Salah Al Awaidy; Wasiq Mehmood Khan
Journal:  J Infect Public Health       Date:  2020-03-03       Impact factor: 3.718

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.